SCHEMBL2500191

SCHEMBL2500191

CC(C)c1ccccc1C1(O)C(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.48
KMT2A Q03164 4/20 0.45
MEN1 O00255 2/20 0.44
POLB P06746 1/20 0.42
CASP6 P55212 1/20 0.42
GAA P10253 2/20 0.41
MGAM O43451 1/20 0.41
HTR1A P08908 1/20 0.41
SI P14410 1/20 0.41
HTR2A P28223 1/20 0.41
HTR7 P34969 1/20 0.41
HTR6 P50406 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
CBX7 O95931 2/20 0.41
CDYL Q9Y232 2/20 0.41
CDYL2 Q8N8U2 1/20 0.41
CDY1; CDY1B Q9Y6F8 1/20 0.41
BRD4 O60885 3/20 0.41
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2497474 0.82 BRD4 (0.57) IDO1KMT2AMEN1POLBCASP6
SCHEMBL27510705 0.82 IDO1 (0.42) IDO1KMT2AMEN1GAAMGAM
SCHEMBL5677834 0.81 KMT2A (0.53) IDO1KMT2AMEN1POLBCASP6
SCHEMBL2499637 0.80 POLB (0.51) IDO1KMT2AMEN1POLBCASP6
SCHEMBL2498146 0.79 IDO1 (0.48) IDO1KMT2AMEN1POLBCASP6
SCHEMBL1464565 0.79 KMT2A (0.72) IDO1KMT2AMEN1POLBCASP6
SCHEMBL2494879 0.79 KMT2A (0.53) IDO1KMT2AMEN1POLBCASP6
SCHEMBL27494971 0.78 IDO1 (0.48) IDO1KMT2AMEN1GAAMGAM
SCHEMBL2497407 0.77 BRD4 (0.52) IDO1KMT2AMEN1POLBCASP6
SCHEMBL2497559 0.77 BRD4 (0.56) IDO1KMT2AMEN1POLBCASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-7528124-B2 1,3-dihydro-2H-indol-2-one derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-05-05 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed
US-20060276449-A1 1,3-Dihydro-2h-indol-2-one derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1659121-A1 1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2006-05-24 EP disclosed
CN-1224623-C 1-phenylsulfonyl-1, 3-dihydro-2H-indol-2-one derivatives, their preparation and their therapeutic use SANOFI ANWANTE (FR) 2005-10-26 CN disclosed
CN-1533387-A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use ����ɳŵ��-����������˾ 2004-09-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276449-A1 1,3-Dihydro-2h-indol-2-one derivative AVPR1B, AVPR2, AVPR1A IDO1 216/4885KMT2A 2040/4885MEN1 353/4885
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 IDO1 4/4885KMT2A 1662/4885MEN1 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.